Education
About Us
Working with TipRanks
Follow Us
Barbara Weber Insider Profile
4 Followers
Barbara Weber, Director at Revolution Medicines, holds 1.63M shares in Tango Therapeutics (Ticker: TNGX), holds 13.06K shares in Revolution Medicines (Ticker: RVMD).
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
-69.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Barbara Weber holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 08, 2024 - Feb 08, 2025
Return:+75.00%
The most profitable trade made by Barbara Weber
Barbara Weber's Trading History
Revolution Medicines
Oct 10, 2024
Director
Uninformative Sell
249.70K
$1.35M
Tango Therapeutics
Feb 04, 2026
Director, Executive Chair, Director
Uninformative Buy
―
$20.58M
List of latest transactions for each holding click on a transaction to see Barbara Weber's performance on stock
You May Also Like
Barbara Weber insider profile FAQ
What is the percentage of profitable transactions made by Barbara Weber?
The percentage of profitable transactions made by Barbara Weber is 67%.
What is the average return per transaction made by Barbara Weber?
The average return per transaction made by Barbara Weber is -69.20%.
What stocks does Barbara Weber hold?
Barbara Weber holds: RVMD, TNGX stocks.
What was Barbara Weber’s latest transaction?
Barbara Weber latest transaction was an Uninformative Buy of ―.
What was Barbara Weber's most profitable transaction?
Barbara Weber’s most profitable transaction was an Informative Sell of TNGX stock on February 8, 2024. The return on the trade was 75.00%.
What is Barbara Weber's role in Revolution Medicines?
Barbara Weber's role in Revolution Medicines is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.